Abstract
Diseases of the brain account for much human suffering and place a huge burden on the health care systems. Thus, research into the pathology of brain diseases and improved pharmacotherapy is of significant value. In this respect, knowledge on malfunctions of metabolic homeostasis related to the neurotransmission process is still limited. As evident from this chapter, failure of the metabolic homeostasis of the two amino acids of major importance, namely glutamate and glutamine, is a hallmark of a wide range of both neurological and psychiatric diseases. This chapter deals with representative brain diseases as well as the methodology of research related to metabolism. In addition, future need for research and potential new targets for pharmacotherapy are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- EAAT:
-
Excitatory amino acid transporter
- GABA:
-
γ-Aminobutyric acid
- GDH:
-
Glutamate dehydrogenase
- GS:
-
Glutamine synthetase
- MCAO:
-
Middle cerebral artery occlusion
- MS:
-
Mass spectrometry
- MSA:
-
Multiple system atrophy
- NMDA:
-
N-methyl-D-aspartate
- NMRS:
-
Nuclear magnetic resonance spectroscopy
- 3-NPA:
-
3-Nitropropionic acid
- PAG:
-
Phosphate-activated glutaminase
- TCA:
-
Tricarboxylic acid
- VGLUT:
-
Vesicular glutamate transporter
References
Almeida A, Delgado-Esteban M, Bolanos JP, Medina JM (2002) Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J Neurochem 81:207–217
Bacci A, Sancini G, Verderio C, Armano S, Pravettoni E, Fesce R, Franceschetti S, Matteoli M (2002) Block of glutamate-glutamine cycle between astrocytes and neurons inhibits epileptiform activity in hippocampus. J Neurophysiol 88:2302–2310
Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98:641–653
Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D (2006) Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6:3414–3425
Belayev L, Zhao W, Busto R, Ginsberg MD (1997) Transient middle cerebral artery occlusion by intraluminal suture: I. Three-dimensional autoradiographic image-analysis of local cerebral glucose metabolism-blood flow interrelationships during ischemia and early recirculation. J Cereb Blood Flow Metab 17:1266–1280
Benjamin AM, Quastel JH (1972) Locations of amino acids in brain slices from the rat. Tetrodotoxin-sensitive release of amino acids. Biochem J 128:631–646
Berl S, Clarke DD (1983) The metabolic compartmentation concept. In: Hertz L, Kvamme E, McGeer EG, Schousboe A (eds) Glutamine, glutamate and GABA in the central nervous system. Liss, New York, NY, pp 205–217
Brenner E, Kondziella D, Håberg A, Sonnewald U (2005) Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801. J Neurochem 94:1594–1603
Brouillet E, Guyot MC, Mittoux V, Altairac S, Conde F, Palfi S, Hantraye P (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794–805
Burbaeva GS, Boksha IS, Tereshkina EB, Savushkina OK, Starodubtseva LI, Turishcheva MS (2005) Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer’s disease patients. Neurochem Res 30:1443–1451
Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237–260
Cater HL, Benham CD, Sundstrom LE (2001) Neuroprotective role of monocarboxylate transport during glucose deprivation in slice cultures of rat hippocampus. J Physiol 531:459–466
Clarke CE, Lowry M, Horsman A (1997) Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson’s disease measured by proton magnetic resonance spectroscopy. Mov Disord 12:297–301
Cowan WM, Kandel ER (2001) Prospects for neurology and psychiatry. JAMA 285:594–600
Danober L, Deransart C, Depaulis A, Vergnes M, Marescaux C (1998) Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 55:27–57
Desagher S, Glowinski J, Premont J (1997) Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci 17:9060–9067
Dufour F, Nalecz KA, Nalecz MJ, Nehlig A (2001a) Metabolic approach of absence seizures in a genetic model of absence epilepsy, the GAERS: study of the leucine-glutamate cycle. J Neurosci Res 66:923–930
Dufour F, Nalecz KA, Nalecz MJ, Nehlig A (2001b) Modulation of absence seizures by branched-chain amino acids: correlation with brain amino acid concentrations. Neurosci Res 40:255–263
Eyjolfsson EM, Brenner E, Kondziella D, Sonnewald U (2006) Repeated injection of MK801: an animal model of schizophrenia? Neurochem Int 48:541–546
Fowler JC (1993) Glucose deprivation results in a lactate preventable increase in adenosine and depression of synaptic transmission in rat hippocampal slices. J Neurochem 60:572–576
Gonzalez SV, Nguyen NH, Rise F, Hassel B (2005) Brain metabolism of exogenous pyruvate. J Neurochem 95:284–293
Hassel B, Sonnewald U (1995) Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo. J Neurochem 65:1184–1191
Henry PG, Lebon V, Vaufrey F, Brouillet E, Hantraye P, Bloch G (2002) Decreased TCA cycle rate in the rat brain after acute 3-NPA treatment measured by in vivo 1H-[13C] NMR spectroscopy. J Neurochem 82:857–866
Huang R, Sochocka E, Hertz L (1997) Cell culture studies of the role of elevated extracellular glutamate and K+ in neuronal cell death during and after anoxia/ischemia. Neurosci Biobehav Rev 21:129–134
Håberg A, Qu H, Haraldseth O, Unsgard G, Sonnewald U (1998) In vivo injection of [1-13C]glucose and [1,2-13C]acetate combined with ex vivo 13C nuclear magnetic resonance spectroscopy: a novel approach to the study of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 18:1223–1232
Håberg A, Qu H, Saether O, Unsgard G, Haraldseth O, Sonnewald U (2001) Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 hours of middle cerebral artery occlusion in the rat: the role of astrocytes in neuronal survival. J Cereb Blood Flow Metab 21:1451–1463
Håberg A, Qu H, Sonnewald U (2006) Glutamate and GABA metabolism in transient and permanent middle cerebral artery occlusion in rat: importance of astrocytes for neuronal survival. Neurochem Int 48:531–540
Jackson JH (1873) On the anatomical, physiological and pathological investigation of epilepsies. West Riding Lunatic Asylum Med Rep 3:315–339
Juttler E, Kohrmann M, Schellinger PD (2006) Therapy for early reperfusion after stroke. Nat Clin Pract Cardiovasc Med 3:656–663
Kondziella D, Brenner E, Eyjolfsson EM, Markinhuhta KR, Carlsson ML, Sonnewald U (2006) Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure. Neuropsychopharmacology 31:1880–1887
Kondziella D, Hammer J, Sletvold O, Sonnewald U (2003) The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: glial-neuronal metabolic interactions. Neurochem Int 43:629–637
Kosenko E, Kaminsky Y, Grau E, Minana MD, Grisolia S, Felipo V (1995) Nitroarginine, an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism. Neurochem Res 20:451–456
Kosenko E, Llansola M, Montoliu C, Monfort P, Rodrigo R, Hernandez-Viadel M, Erceg S, Sanchez-Perez AM, Felipo V (2003) Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide. Neurochem Int 43:493–499
Kvamme E, Torgner IA, Roberg B (2001) Kinetics and localization of brain phosphate activated glutaminase. J Neurosci Res 66:951–958
Lin AP, Shic F, Enriquez C, Ross BD (2003) Reduced glutamate neurotransmission in patients with Alzheimer’s disease – an in vivo 13C magnetic resonance spectroscopy study. MAGMA 16:29–42
Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91
Mally J, Szalai G, Stone TW (1997) Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson’s disease. J Neurol Sci 151:159–162
Mastrogiacomo F, Kish SJ (1994) Cerebellar Alpha-Ketoglutarate Dehydrogenase-Activity Is Reduced in Spinocerebellar Ataxia Type-1. Ann Neurol 35:624–626
Matute C, Meløne M, Vallejo-Illarramendi A, Conti F (2005) Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics. Glia 49:451–455
McKenna MC, Gruetter R, Sonnewald U, Waagepetersen HS, Schousboe A (2006) Energy metabolism of the brain. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier, Amsterdam, pp 531–557
Melø TM, Nehlig A, Sonnewald U (2005) Metabolism is normal in astrocytes in chronically epileptic rats: a 13C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J Cereb Blood Flow Metab 25:1254–1264
Melø TM, Sonnewald U, Touret M, Nehlig A (2006) Cortical glutamate metabolism is enhanced in a genetic model of absence epilepsy. J Cereb Blood Flow Metab 26:1496–1506
Miret-Duvaux O, Frederic F, Simon D, Guenet JL, Hanauer A, Delhaye-Bouchaud N, Mariani J (1990) Glutamate dehydrogenase in cerebellar mutant mice: gene localization and enzyme activity in different tissues. J Neurochem 54:23–29
Nanitsos EK, Nguyen KT, St’astny F, Balcar VJ (2005) Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport. J Biomed Sci 12:975–984
Norenberg MD, Martinez-Hernandez A (1979) Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161:303–310
Ohrmann P, Siegmund A, Suslow T, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B (2005) Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 73:153–157
Okada Y, Lipton P (2007) Glucose, oxidative energy metabolism, and neuronal function in brain slices-glycolysis plays a key role in neural activity. In: Gibson GE, Dienel G (eds) Handbook of neurochemistry and molecular neurobiology Springer-Verlag, Heidelburg, Germany, vol 5. pp 17–39
Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360–1362
Ottersen OP, Zhang N, Walberg F (1992) Metabolic compartmentation of glutamate and glutamine: morphological evidence obtained by quantitative immunocytochemistry in rat cerebellum. Neuroscience 46:519–534
Perry TL, Kish SJ, Hansen S, Currier RD (1981) Neurotransmitter amino acids in dominantly inherited cerebellar disorders. Neurology 31:237–242
Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD (2002) Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 43:703–710
Plaitakis A, Flessas P, Natsiou AB, Shashidharan P (1993) Glutamate dehydrogenase deficiency in cerebellar degenerations: clinical, biochemical and molecular genetic aspects. Can J Neurol Sci 20(Suppl 3):S109–S116
Plaitakis A, Nicklas WJ, Desnick RJ (1979) Glutamate dehydrogenase deficiency in three patients with spinocerebellar ataxia: a new enzymatic defect? Trans Am Neurol Assoc 104:54–57
Plaitakis A, Nicklas WJ, Desnick RJ (1980) Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome. Ann Neurol 7:297–303
Podell M, Hadjiconstantinou M, Smith MA, Neff NH (2003) Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism. Exp Neurol 179:159–166
Qu H, Håberg A, Haraldseth O, Unsgard G, Sonnewald U (2000) 13C MR spectroscopy study of lactate as substrate for rat brain. Dev Neurosci 22:429–436
Rae C, Moussa C, Griffin JL, Bubb WA, Wallis T, Balcar VJ (2005) Group I and II metabotropic glutamate receptors alter brain cortical metabolic and glutamate/glutamine cycle activity: a 13C NMR spectroscopy and metabolomic study. J Neurochem 92:405–416
Re DB, Nafia I, Meløn C, Shimamoto K, Goff LK, Had-Aissouni L (2006) Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport. Glia 54:47–57
Robinson SR (2000) Neuronal expression of glutamine synthetase in Alzheimer’s disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem Int 36:471–482
Robinson SR (2001) Changes in the cellular distribution of glutamine synthetase in Alzheimer’s disease. J Neurosci Res 66:972–980
Rossi DJ, Oshima T, Attwell D (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403:316–321
Sarup A, Larsson OM, Schousboe A (2003) GABA transporters and GABA-transaminase as drug targets. Curr Drug Targets CNS Neurol Disord 2:269–277
Schurr A, Payne RS, Miller JJ, Rigor BM (1997a) Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. J Neurochem 69:423–426
Schurr A, Payne RS, Miller JJ, Rigor BM (1997b) Brain lactate, not glucose, fuels the recovery of synaptic function from hypoxia upon reoxygenation: an in vitro study. Brain Res 744:105–111
Schurr A, Payne RS, Miller JJ, Rigor BM (1997c) Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia. Brain Res 774:221–224
Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH (2001a) Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry 158:1393–1399
Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH (2001b) Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia. Neuroreport 12:2885–2887
Sonnewald U, Kondziella D (2003) Neuronal glial interaction in different neurological diseases studied by ex vivo 13C NMR spectroscopy. NMR Biomed 16:424–429
Taylor A, McLean M, Morris P, Bachelard H (1996) Approaches to studies on neuronal/glial relationships by 13C-NMRS analysis. Dev Neurosci 18:434–442
Taylor-Robinson SD, Turjanski N, Bhattacharya S, Seery JP, Sargentoni J, Brooks DJ, Bryant DJ, Cox IJ (1999) A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson’s disease. Metab Brain Dis 14:45–55
Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O’Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr., Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P (2006) Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85–e151
Thoren AE, Helps SC, Nilsson M, Sims NR (2005) Astrocytic function assessed from 1-14C-acetate metabolism after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab 25:440–450
Thoren AE, Helps SC, Nilsson M, Sims NR (2006) The metabolism of 14C-glucose by neurons and astrocytes in brain subregions following focal cerebral ischemia in rats. J Neurochem 97:968–978
Waagepetersen HS, Schousboe A, Sonnewald U (2007) Glutamate, glutamine and GABA: metabolic aspects. In: Oja SS, Schousboe A, Saransaari P (eds) Handbook of neurochemistry and molecular neurobiology Springer-Verlag, Heidelburg, Germany, vol 6. pp 1–21
Waagepetersen HS, Sonnewald U, Larsson OM, Schousboe A (1999) Synthesis of vesicular GABA from glutamine involves TCA cycle metabolism in neocortical neurons. J Neurosci Res 57:342–349
Waniewski RA, Martin DL (1998) Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 18:5225–5233
van den Berg CJ, Garfinkel D (1971) A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. Biochem J 123:211–218
van Elst LT, Valerius G, Buchert M, Thiel T, Rusch N, Bubl E, Hennig J, Ebert D, Olbrich HM (2005) Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 58:724–730
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bak, L.K., Schousboe, A., Waagepetersen, H.S. (2011). Glutamate and Glutamine in Brain Disorders. In: Blass, J. (eds) Neurochemical Mechanisms in Disease. Advances in Neurobiology, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7104-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7104-3_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7103-6
Online ISBN: 978-1-4419-7104-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)